Determinants of length of stay in surgical ward after coronary bypass surgery: Glycosylated hemoglobin as a predictor in all patients, diabetic or non-diabetic

Journal of Tehran University Heart Center

Volumn 7, Issue 4, 2012, Pages 170-176

  Najafi, Mahdi ^a   Goodarzynejad, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery bypass; Glycosylated; Hemoglobin a; Length of stay; Treatment outcome

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEMOGLOBIN ANALYSIS; HUMAN; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SURGICAL WARD;

EID: 84872051667     PISSN: 17358620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nilsson J, Algotsson L, Höglund P, Lührs C, Brandt J. EuroSCORE predicts intensive care unit stay and costs of open heart surgery. Ann Thorac Surg 2004;78:1528-1534.
2. Riordan CJ, Engoren M, Zacharias A, Schwann TA, Parenteau GL, Durham SJ, Habib RH. Resource utilization in coronary artery bypass operation: does surgical risk predict cost? Ann Thorac Surg 2000;69:1092-1097.
3. Doering LV, Esmailian F, Laks H. Perioperative predictors of ICU and hospital costs in coronary artery bypass graft surgery. Chest 2000;118:736-743.
4. Tuman KJ, McCarthy RJ, March RJ, Najafi H, Ivankovich AD. Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment. Chest 1992;102:36-44.
5. Tu JV, Mazer CD, Levinton C, Armstrong PW, Naylor CD. A predictive index for length of stay in the intensive care unit following cardiac surgery. CMAJ 1994;151:177-185.
6. Michalopoulos A, Tzelepis G, Pavlides G, Kriaras J, Dafni U, Geroulanos S. Determinants of duration of ICU stay after coronary artery bypass graft surgery. Br J Anaesth 1996;77:208-212.
7. Christakis GT, Fremes SE, Naylor CD, Chen E, Rao V, Goldman BS. Impact of preoperative risk and perioperative morbidity on ICU stay following coronary bypass surgery. Cardiovasc Surg 1996;4:29-35.
8. Ryan TA, Rady MY, Bashour CA, Leventhal M, Lytle B, Starr NJ. Predictors of outcome in cardiac surgical patients with prolonged intensive care stay. Chest 1997;112:1035-1042.
9. Doering LV, Esmailian F, Imperial-Perez F, Monsein S. Determinants of intensive care unit length of stay after coronary artery bypass graft surgery. Heart Lung 2001;30:9-17.
10. Janssen DP, Noyez L, Wouters C, Brouwer RM. Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery. Eur J Cardiothorac Surg 2004;25:203-207.
11. Ghotkar SV, Grayson AD, Fabri BM, Dihmis WC, Pullan DM. Preoperative calculation of risk for prolonged intensive care unit stay following coronary artery bypass grafting. J Cardiothorac Surg 2006;1:14.
12. Rosenfeld R, Smith JM, Woods SE, Engel AM. Predictors and outcomes of extended intensive care unit length of stay in patients undergoing coronary artery bypass graft surgery. J Card Surg 2006;21:146-150.
13. Weintraub WS, Jones EL, Craver J, Guyton R, Cohen C. Determinants of prolonged length of hospital stay after coronary bypass surgery. Circulation 1989;80:276-284.
14. Mounsey JP, Griffith MJ, Heaviside DW, Brown AH, Reid DS. Determinants of the length of stay in intensive care and in hospital after coronary artery surgery. Br Heart J 1995;73:92-98.
15. Lazar HL, Fitzgerald C, Gross S, Heeren T, Aldea GS, Shemin RJ. Determinants of length of stay after coronary artery bypass graft surgery. Circulation 1995;92:II20-24.
16. Jensen L, Yang L. Risk factors for postoperative pulmonary complications in coronary artery bypass graft surgery patients. Eur J Cardiovasc Nurs 2007;6:241-246.
17. Najafi M, Goodarzinejad H, Sheikhfathollahi M, Adibi H. Role of surgeon in length of stay in ICU after cardiac bypass surgery. J Teh Univ Heart Ctr 2010;1:9-13.
18. Wong DT, Cheng DC, Kustra R, Tibshirani R, Karski J, Carroll-Munro J, Sandler A. Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score. Anesthesiology 1999;91:936-944.
19. Bucerius J, Gummert JF, Walther T, Doll N, Falk V, Schmitt DV, Mohr FW. Predictors of prolonged ICU stay after on-pump versus off-pump coronary artery bypass grafting. Intensive Care Med 2004;30:88-95.
20. Hein OV, Birnbaum J, Wernecke K, England M, Konertz W, Spies C. Prolonged intensive care unit stay in cardiac surgery: risk factors and long-term-survival. Ann Thorac Surg 2006;81:880-885.
21. Staat P, Cucherat M, George M, Lehot JJ, Jegaden O, André-Fouët X, Beaune J. Severe morbidity after coronary artery surgery: development and validation of a simple predictive clinical score. Eur Heart J 1999;20:960-966.
22. Kurki TS, Kataja M. Preoperative prediction of postoperative morbidity in coronary artery bypass grafting. Ann Thorac Surg 1996;61:1740-1745.
23. Miller KH. Factors influencing selected lengths of ICU stay for coronary artery bypass patients. J Cardiovasc Nurs 1998;12:52-61.
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:S62-69.
25. Silbernagel G, Grammer TB, Winkelmann BR, Boehm BO, März W. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care 2011;34:1355-1361.
26. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811.
27. Liu Y, Yang YM, Zhu J, Tan HQ, Liang Y, Li JD. Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovasc Diabetol 2011;10:98.
28. Medhi M, Marshall MC, Jr, Burke HB, Hasan R, Nayak D, Reed G, LaFaro R, Southren AL. HbA1c predicts length of stay in patients admitted for coronary artery bypass surgery. Heart Dis 2001;3:77-79.
29. O'Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, Lowery A, Sultan S. Haemoglobin A1c (HbA1C) in nondiabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg 2006;32:188-197.
30. Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Bragadeesh T, Clark AL, Cleland JG. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart 2009;95:917-923.